Lier Chemical: core product sales prices fell, the first half of the net profit fell 53.7%-54.66%
Lier Chemical released a performance forecast on July 6, the company is expected in the first half of 2023 attributable to shareholders of listed companies net profit of 475 million to 485 million yuan, down 53.7% to 54.66%; Basic earnings per share 0.5934 yuan to 0.6059 yuan.
The announcement said that the main reason for the change in performance was that in the first half of 2023, the company's core product competition was intensified, resulting in a sharp decline in product sales prices year-on-year, resulting in a year-on-year decline in the company's performance.
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$1.8E+2/UNIT FOB
2026-08-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S.-Iran Détente Triggers Oil Price Plunge, Energy and Chemical Sectors Tumble
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
AUTOMA Chem 2026: Powering Industry 4.0 in Chemistry
-
Chemical Raw Materials: How to Source Quality Suppliers & Understand Grades
-
The project with an investment of ￥105 million and an annual output of 4000 tons of Propargite is to be built
-
BAL became the first local company in India to register a 96% Haloxyfop-R-methyl ester Technical
-
Big adjustment! Basf quietly closed 11 factories in Germany and transferred to China for plant investment!
-
Quanfeng's Chlormequat chloride is registered as equivalent in the European Union
-
Fluorine chemical: profit generally declined, under the pressure to expand profit space
Recommend Reading
-
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
-
Dow × Hisense’s Innovation Code: A Deep Game of Sustainability
-
AstraZeneca to Invest $2 Billion in New U.S. Biologics Facilities
-
BASF Builds New Alkyl Polyglucoside Plant in Thailand, Expands Its Business Footprint in Asia
-
The FDA Officially Blesses AI for Liver Drug Development
-
Fundamentals Weak, TDI Market in China Declines in October
-
Demand Fails to Expand, ABS Struggles Through Golden September
-
October Palm Oil Market Fluctuates and Falls
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants